pet-ct

Documents about pet-ct

• 18 F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study#670155HAL (France)
• Utility of 18F-FDG PET/CT for Suspected Infection in the Inpatient Setting: a Single Centre Retrospective Cohort Study#839398ClinicalTrials.gov
• 18-FDG PET/CT Imaging and Clinical Decisions in Infective Endocarditis#806471ClinicalTrials.gov
• 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma#860217ClinicalTrials.gov
• Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors#993053ClinicalTrials.gov
• Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model#835275ClinicalTrials.gov
• Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain#846667ClinicalTrials.gov
• Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases#887353ClinicalTrials.gov
• Clinical Evaluation of an Integrated PET/MRI System#849483ClinicalTrials.gov
• 68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients#1009488ClinicalTrials.gov
• Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)#890909ClinicalTrials.gov
• 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients#800619ClinicalTrials.gov
• [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer#833202ClinicalTrials.gov
• Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation#846392ClinicalTrials.gov
• PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105#866550ClinicalTrials.gov
• GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer#874514ClinicalTrials.gov
• Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer#904128ClinicalTrials.gov
• Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System#916420ClinicalTrials.gov
• Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies#1008255ClinicalTrials.gov
• Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging System#899788ClinicalTrials.gov
• The Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism Patients#1008288ClinicalTrials.gov
• The Research on 89Zr-ABT806 PET Imaging in High Grade Glioma#853856ClinicalTrials.gov
• PET-CT After Nellix Implantation#855702ClinicalTrials.gov
• Autoimmune encephalitis: clinical correlation with 18F-FDG PET/CT#233010Repositório de Dados de Pesquisa da Unicamp Dataverse OAI Archive
• PLACE OF THE 18F-FDG-PET/CT IN THE DIAGNOSTIC WORKUP IN PATIENTS WITH CLASSICAL FEVER OF UNKNOWN ORIGIN (FUO)#909090ClinicalTrials.gov
• PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2#981803ClinicalTrials.gov
• Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT#1007068ClinicalTrials.gov
• Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer#892753ClinicalTrials.gov
• Positron Emission Tomography (PET) Images Using Deep Neural Networks#810592ClinicalTrials.gov
• Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol#910424ClinicalTrials.gov
• Identification of PET/CT radiomic signature for classification of locally recurrent rectal cancer: A network-based feature selection approach#442677IRIS
• Using [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patients#860863ClinicalTrials.gov
• Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer#871376ClinicalTrials.gov
• Diagnostic Value of Spinal Cord Lesion Metabolism on [ 18 F ] FDG PET / CT for the Classification of Myelopathy#971173HAL (France)
• 18F-FAPI PET/CT and MRI in Gastric Cancer#812793ClinicalTrials.gov
• [18F]FES PET/.CT in Uterine Cancer#832044ClinicalTrials.gov
• Study of the Angiogenesis by PET/CT in Patients With Lymphoma#850190ClinicalTrials.gov
• Improved 2.5D-UNet pseudo-CT generation for attenuation correction in PET imaging using 18F-fluorodeoxyglucose and 11C-acetoacetate radiotracers#685119HAL (France)
• PET/CT variants and pitfalls in malignant melanoma#669948HAL (France)
• Evaluation of a New Generation of PET-CT OMNI#905297ClinicalTrials.gov
• Ultralow Dose PET Imaging of 18F-flurpiridaz#836055ClinicalTrials.gov
• Texture Features and PDL1 in CT-PET 18 FDG#866269ClinicalTrials.gov
• 68Ga-BCMA PET/CT in Multiple Myeloma#991969ClinicalTrials.gov
• Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.#832436ClinicalTrials.gov
• RGD PET/CT Imaging in COVID-19 Patients#838133ClinicalTrials.gov
• PET-CT vs. Integrated MR-PET Scanning of GYN Cancers#909977ClinicalTrials.gov
• Comparison of Volumetric Quantitative PET Parameters Before and After a CT-Based Elastic Deformation on Dual-Time 18FDG-PET/CT Images: A Feasibility Study in a Perspective of Radiotherapy Planning in Head and Neck Cancer#983793HAL (France)
• Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data#969365ClinicalTrials.gov
• Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake#980813ClinicalTrials.gov
• Study of Value of Cardiac PET Scans With or Without CT Angiography and/or Measurement of Coronary Flow Reserve#850127ClinicalTrials.gov